Video - European Medical Journal

Continue

Videos

EMJ
Oncology
5 Feb 2016

LUX-H&N1: Phase 3 trial of afatinib versus methotrexate for head and neck squamous cell carcinoma

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
EMJ
Oncology
5 Feb 2016

ESMO Clinical Practice Guidelines: Breast cancer case presentation

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Fatima Cardoso, MD, from…
EMJ
Oncology
5 Feb 2016

Balancing therapeutics and patient access to new cancer drugs

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, ESMO and Congress…
EMJ
Oncology
4 Feb 2016

Updates from CheckMate 017 and CheckMate 057: Nivolumab, anti-PD1, for non-small cell lung cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Martin Reck, MD, PhD…
EMJ
Oncology
4 Feb 2016

Olaparib: An opportunity for personalised medicine in BRCA-related ovarian cancer

Recently, there have been numerous advances in the biological understanding of ovarian cancer. At the European Society for Medical Oncology (ESMO) Asia…
EMJ
Oncology
4 Feb 2016

Optimising sequencing of new treatments for prostate cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Karim Fizazi, MD, PhD…
EMJ
Oncology
4 Feb 2016

A new definition of genetic counselling for ovarian cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Jonathan A. Ledermann…
EMJ
Oncology
4 Feb 2016

KEYNOTE-010: Pembrolizumab, anti-PD-1, for advanced NSCLC with PD-L1 expression

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Roy S. Herbst, MD, PhD…